Psychedelic Therapeutics Market Revenue to Attain USD 9.53 Bn by 2033

20 Oct 2025

Share :

Table of Content

1. Psychedelic Therapeutics Market Revenue and Trends 2025 to 2033 2. Increasing Attention to Treating Mental Health 3. Segmental Analysis 4. Regional Analysis 5. Psychedelic Therapeutics Market Coverage

Psychedelic Therapeutics Market Revenue and Trends 2025 to 2033

The global psychedelic therapeutics market revenue reached USD 2.94 billion in 2025 and is predicted to attain around USD 9.53 billion by 2033 with a CAGR of 15.82%. The psychedelic therapeutics market is growing with rising maternal health awareness, technological advancements in point-of-care testing and increasing prenatal screening initiatives.

Increasing Attention to Treating Mental Health

The market for psychedelic therapies is experiencing strong growth as awareness of mental health disorders increases along with clinical research demonstrating the efficacy of psychedelic-assisted therapy. The acceptance of psychedelic compounds to treat conditions such as depression, PTSD, and anxiety among treatment providers in healthcare settings is driving increased adoption throughout healthcare.

The market encompasses the development and commercialization of therapeutic drugs based on psychedelics such as psilocybin, MDMA, LSD, and ketamine. While there continues to be regulatory hurdles to come, and gaining breakthrough therapy status by the regulatory authority, the psychedelic therapy market for mental health treatment is moving smoothly towards widespread medical practice.

Segmental Analysis

• By Molecule / Class- Grow factors lead in market share because they facilitate cell repair and tissue regeneration. They have a versatile set of therapeutic uses inducing wound healing, reducing scarring, and skin rejuvenation, which underpins clinical interest.
• By Indication / Disease area- Chronic wound healing leads in market share due to rising cases of diabetic, pressure and other chronic ulceration. Regenerating therapies provide therapeutic benefit by promoting healing through wound repair while reducing patient infection risk.
• By Therapy Model- Stem Cell-based therapies lead in market share due to improving, restoring and regeneration damaged skin structures. They also provide therapeutic benefit for burns scars and aging skin, thus attracting clinical interest.
• By Route / Formulation- Insertion comes from topical and injectable routes as they pose the least amount of risk and provide focused therapeutic efficacy. Formulations that can be applied at the site of action provide the quickest absorbance and visible regeneration results.
• By End-User- Dermatology clinics dominate the end-user segment of regenerative treatment for treatment of both therapeutic and cosmetic skin concerns. In particular, availability of regenerative treatment leads to more patient-specific regenerative care.

Regional Analysis

In North America, access is being facilitated through legal and regulatory changes. For instance, in Colorado, psilocybin therapy has been legalized in regulated settings where licensed healing centers must use trained facilitators.  Federal regulators are also issuing breakthrough designations and financial support for clinical trials of various other substances (MDMA, psilocybin, ibogaine) in studies of PTSD, depression and addiction. The strong investment from both sectors reflects scaling up of the infrastructure clinics, academic centres, training programs.  

The Asia-Pacific region, through research into psychedelics and regulatory changes in addition to planning trials, is emerging rapidly. Australia is opening clinical trial sites alongside preparing for full Phase IIb studies.  Thailand has recently authorized the medical/research use of psilocybin mushrooms, putting together the following observational study, supported by supply partnership. Small regional research consortia like the Asia-Pacific Consortium for Advancing Clinical Psychedelic Medicine, which will bring Malaysia, Australia etc. together illustrate growing coordination and ambitions.  While there are several barriers to overcome including some cultural stigma and regulatory progress being slower in many of the countries, the momentum is great.

Psychedelic Therapeutics Market Coverage

Recent Developments

• In June 2025, Transformation Counseling, LLC, launched the psychedelic-assisted therapy services, these are legally offered under Schroeder’s licensure as a psilocybin facilitator in Oregon and Colorado and supported by advanced clinical training.
  (Source: https://www.wcia.com)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6998

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344